Library design for fragment based screening.
暂无分享,去创建一个
Edgar Jacoby | Ansgar Schuffenhauer | Wolfgang Jahnke | W. Jahnke | E. Jacoby | A. Schuffenhauer | P. Selzer | M. Blommers | A. Marzinzik | S. Ruedisser | Simon Ruedisser | Andreas L Marzinzik | Marcel Blommers | Paul Selzer
[1] Christopher W Murray,et al. Fragment-based lead discovery using X-ray crystallography. , 2005, Journal of medicinal chemistry.
[2] R. Griffey,et al. Measuring dissociation constants of RNA and aminoglycoside antibiotics by electrospray ionization mass spectrometry. , 2000, Analytical biochemistry.
[3] Renaldo Mendoza,et al. ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens. , 2005, Journal of the American Chemical Society.
[4] G. Fogliatto,et al. WaterLOGSY as a method for primary NMR screening: Practical aspects and range of applicability , 2001, Journal of biomolecular NMR.
[5] Vicki L. Nienaber,et al. Discovering novel ligands for macromolecules using X-ray crystallographic screening , 2000, Nature Biotechnology.
[6] P. Hajduk,et al. NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein. , 1997, Journal of medicinal chemistry.
[7] P. Taylor,et al. Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks. , 2002, Angewandte Chemie.
[8] W. Guida,et al. The art and practice of structure‐based drug design: A molecular modeling perspective , 1996, Medicinal research reviews.
[9] Ajay,et al. The SHAPES strategy: an NMR-based approach for lead generation in drug discovery. , 1999, Chemistry & biology.
[10] John Davies,et al. Design of small molecule libraries for NMR screening and other applications in drug discovery. , 2002, Current topics in medicinal chemistry.
[11] Marcel L. Verdonk,et al. The consequences of translational and rotational entropy lost by small molecules on binding to proteins , 2002, J. Comput. Aided Mol. Des..
[12] Andrew R. Leach,et al. Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery , 2001, J. Chem. Inf. Comput. Sci..
[13] Brian Dymock,et al. Design and Characterization of Libraries of Molecular Fragments for Use in NMR Screening against Protein Targets , 2004, J. Chem. Inf. Model..
[14] Daniel A. Erlanson,et al. Fragment‐Based Drug Discovery. , 2004 .
[15] P. Hajduk,et al. Druggability indices for protein targets derived from NMR-based screening data. , 2005, Journal of medicinal chemistry.
[16] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.
[17] M. Congreve,et al. A 'rule of three' for fragment-based lead discovery? , 2003, Drug discovery today.
[18] Peter Ertl,et al. Cheminformatics Analysis of Organic Substituents: Identification of the Most Common Substituents, Calculation of Substituent Properties, and Automatic Identification of Drug‐Like Bioisosteric Groups. , 2003 .
[19] Tudor I. Oprea,et al. Pursuing the leadlikeness concept in pharmaceutical research. , 2004, Current opinion in chemical biology.
[20] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[21] Patricia C Weber,et al. Applications of calorimetric methods to drug discovery and the study of protein interactions. , 2003, Current opinion in structural biology.
[22] R. Griffey,et al. SAR by MS: a ligand based technique for drug lead discovery against structured RNA targets. , 2002, Journal of medicinal chemistry.
[23] A. Hopkins,et al. Ligand efficiency: a useful metric for lead selection. , 2004, Drug discovery today.
[24] Stephen W. Fesik,et al. One-Dimensional Relaxation- and Diffusion-Edited NMR Methods for Screening Compounds That Bind to Macromolecules , 1997 .
[25] Christopher A. Lepre,et al. Strategies for NMR Screening and Library Design , 2003 .
[26] A. Ghose,et al. Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods , 1998 .
[27] E B Reilly,et al. Novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. 2. Mechanism of inhibition and structure-based improvement of pharmaceutical properties. , 2001, Journal of medicinal chemistry.
[28] I. Kuntz,et al. The maximal affinity of ligands. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[29] G. Rishton. Nonleadlikeness and leadlikeness in biochemical screening. , 2003, Drug discovery today.
[30] Hugo O. Villar,et al. Comments on the design of chemical libraries for screening , 2004, Molecular Diversity.
[31] Wolfgang Jahnke,et al. Second-site NMR screening and linker design. , 2003, Current topics in medicinal chemistry.
[32] Karl A. Walter,et al. ChemInform Abstract: Discovery of Potent Nonpeptide Inhibitors of Stromelysin Using SAR by NMR. , 1997 .
[33] P. Hajduk,et al. Novel inhibitors of Erm methyltransferases from NMR and parallel synthesis. , 1999, Journal of medicinal chemistry.
[34] A. Schuffenhauer,et al. Complex molecules: do they add value? , 2005, Current opinion in chemical biology.
[35] R. Cramer,et al. Toward general methods of targeted library design: topomer shape similarity searching with diverse structures as queries. , 2000, Journal of medicinal chemistry.
[36] C. Craik,et al. Design and synthesis of novel inhibitors of gelatinase B. , 2002, Bioorganic & medicinal chemistry letters.
[37] D. Kostrewa,et al. Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening. , 2000, Journal of medicinal chemistry.
[38] S D Pickett,et al. Design of a compound screening collection for use in high throughput screening. , 2004, Combinatorial chemistry & high throughput screening.
[39] Michael M. Hann,et al. RECAP — Retrosynthetic Combinatorial Analysis Procedure: A Powerful New Technique for Identifying Privileged Molecular Fragments with Useful Applications in Combinatorial Chemistry. , 1998 .
[40] Jean M. Severin,et al. Design of adenosine kinase inhibitors from the NMR-based screening of fragments. , 2000, Journal of medicinal chemistry.
[41] M. Congreve,et al. Fragment-based lead discovery , 2004, Nature Reviews Drug Discovery.
[42] U Schopfer,et al. Molecular diversity management strategies for building and enhancement of diverse and focused lead discovery compound screening collections. , 2004, Combinatorial chemistry & high throughput screening.
[43] Pierre Acklin,et al. Similarity Metrics for Ligands Reflecting the Similarity of the Target Proteins , 2003, J. Chem. Inf. Comput. Sci..
[44] Gang Liu,et al. Selective protein tyrosine phosphatase 1B inhibitors: targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands. , 2003, Journal of medicinal chemistry.
[45] E. Freire,et al. Direct measurement of protein binding energetics by isothermal titration calorimetry. , 2001, Current opinion in structural biology.
[46] Jeffrey W. Peng,et al. Theory and Applications of NMR‐Based Screening in Pharmaceutical Research , 2004 .
[47] M. Uesugi,et al. [Discovering high-affinity ligands for proteins: SAR by NMR]. , 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[48] Dustin J Maly,et al. Combinatorial target-guided ligand assembly: identification of potent subtype-selective c-Src inhibitors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[49] Bohdan Waszkowycz,et al. PRO_SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors. , 2002, Journal of medicinal chemistry.
[50] Xiaoling Xie,et al. Application of NMR screening in drug discovery. , 2003, Current topics in medicinal chemistry.